2'-DEOXYCYTIDINE-5'-TRIPHOSPHATE TRISODI Inhibitor

2'-DEOXYCYTIDINE-5'-TRIPHOSPHATE TRISODI Oxidation contributes to antibiotic lethality in stationary-phase mycobacteria.

Br J Clin Pharmacol. 2000 Dec;50(6):597-604.et al. The intracellular activation of lamivudine (3TC) and determination of 2'-deoxycytidine-5'-triphosphate (dCTP) pools in the presence and absence of various drugs in HepG2 cells.Kewn S, Hoggard PG, Sales SD
Br J Clin Pharmacol. 2000 Dec;50(6):597-604.et al. The intracellular activation of lamivudine (3TC) and determination of 2'-deoxycytidine-5'-triphosphate (dCTP) pools in the presence and absence of various drugs in HepG2 cells.Kewn S, Hoggard PG, Sales SD
Fan, Xiao-Yong, Tang, et al. Oxidation of dCTP contributes to antibiotic lethality in stationary-phase mycobacteria[J]. Proceedings of the National Academy of Sciences of the United States of America. 2018.
Fan, Xiao-Yong, Tang, et al. Oxidation of dCTP contributes to antibiotic lethality in stationary-phase mycobacteria[J]. Proceedings of the National Academy of Sciences of the United States of America. 2018.

Small volumes of 2'-DEOXYCYTIDINE-5'-TRIPHOSPHATE TRISODI, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

MBS5758409 is an inhibitor targeting 2'-DEOXYCYTIDINE-5'-TRIPHOSPHATE TRISODI.